Saltar al contenido
Merck
  • Synthesis and initial results for MAO-B inhibition by new N-propargyl-3-pyrrol-1-ylindanamine derivatives, analogues of rasagiline.

Synthesis and initial results for MAO-B inhibition by new N-propargyl-3-pyrrol-1-ylindanamine derivatives, analogues of rasagiline.

Journal of enzyme inhibition and medicinal chemistry (2003-08-29)
Jean Guillon, Guillaume Hébert, Patrick Dallemagne, Jean-Michel Léger, Céline Vidaillac, Corinne Thé, Vincent Lisowski, Sylvain Rault, Jacques Demotes-Mainard, Christian Jarry
RESUMEN

The syntthesis of new N-propargyl-3-pyrrol-1-ylindanamine derivatives, analogues of rasagiline, is described in ten steps starting from the corresponding arylaldehydes via the corresponding cis-3-pyrrol-1-ylindanamines. The cis-configuration of some intermediates has been established using X-ray analysis and NOE experiments. The new N-propargyl-3-pyrrol-1-ylindanamine derivatives were evaluated for their potential MAO-B inhibitor activity in an in vivo model of MPTP-induced Parkinsonism in mice with respect to the potent MAO-B inhibitor rasagiline.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Roche
Reactivo de transfección de ADN X-tremeGENE 9, Polymer reagent for transfecting common cell lines